Atlas Trials

Blood and imagE-guided Optimization of Neoadjuvant Therapy in People With Early Stage Triple-negative Breast cancER - the BETTER Trial

Clinical trial NCT07610525 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07610525
Sponsor
M.D. Anderson Cancer Center
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Triple Negative Breast CancerBlood and Image GuidedOptimization of Neoadjuvant TherapyPhase 2
Start date
2026-11-05
Primary completion
2029-01-15
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.